141 related articles for article (PubMed ID: 32134383)
21. Integrative Metabolomics to Identify Molecular Signatures of Responses to Vaccines and Infections.
Diray-Arce J; Conti MG; Petrova B; Kanarek N; Angelidou A; Levy O
Metabolites; 2020 Nov; 10(12):. PubMed ID: 33266347
[TBL] [Abstract][Full Text] [Related]
22. The Diversity Outbred Mouse Population Is an Improved Animal Model of Vaccination against Tuberculosis That Reflects Heterogeneity of Protection.
Kurtz SL; Rossi AP; Beamer GL; Gatti DM; Kramnik I; Elkins KL
mSphere; 2020 Apr; 5(2):. PubMed ID: 32295871
[TBL] [Abstract][Full Text] [Related]
23. Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters.
Sarathy JP; Dartois V
Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32238365
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease.
Kayongo A; Nyiro B; Siddharthan T; Kirenga B; Checkley W; Lutaakome Joloba M; Ellner J; Salgame P
Front Cell Infect Microbiol; 2023; 13():1146571. PubMed ID: 37415827
[TBL] [Abstract][Full Text] [Related]
25. HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an "Emerging Syndemic".
Azevedo-Pereira JM; Pires D; Calado M; Mandal M; Santos-Costa Q; Anes E
Microorganisms; 2023 Mar; 11(4):. PubMed ID: 37110276
[TBL] [Abstract][Full Text] [Related]
26. Attenuated Cytokine-Induced Memory-Like Natural Killer Cell Responses to
Liang C; Li S; Yuan J; Song Y; Ren W; Wang W; Shang Y; Tang S; Pang Y
Infect Drug Resist; 2023; 16():2349-2364. PubMed ID: 37101462
[TBL] [Abstract][Full Text] [Related]
27. Maintenance and recall of memory T cell populations against tuberculosis: Implications for vaccine design.
Liu X; Li H; Li S; Yuan J; Pang Y
Front Immunol; 2023; 14():1100741. PubMed ID: 37063832
[TBL] [Abstract][Full Text] [Related]
28. Infectious and Inflammatory Pathways to Cough.
Naqvi KF; Mazzone SB; Shiloh MU
Annu Rev Physiol; 2023 Feb; 85():71-91. PubMed ID: 36170660
[TBL] [Abstract][Full Text] [Related]
29. Anti-tuberculosis treatment strategies and drug development: challenges and priorities.
Dartois VA; Rubin EJ
Nat Rev Microbiol; 2022 Nov; 20(11):685-701. PubMed ID: 35478222
[TBL] [Abstract][Full Text] [Related]
30. Heterologous Production of 1-Tuberculosinyladenosine in Mycobacterium kansasii Models Pathoevolution towards the Transcellular Lifestyle of Mycobacterium tuberculosis.
Ghanem M; Dubé JY; Wang J; McIntosh F; Houle D; Domenech P; Reed MB; Raman S; Buter J; Minnaard AJ; Moody DB; Behr MA
mBio; 2020 Oct; 11(5):. PubMed ID: 33082253
[No Abstract] [Full Text] [Related]
31. Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.
Abreu R; Giri P; Quinn F
Front Immunol; 2020; 11():1553. PubMed ID: 32849525
[TBL] [Abstract][Full Text] [Related]
32. Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment.
Gopalaswamy R; Shanmugam S; Mondal R; Subbian S
J Biomed Sci; 2020 Jun; 27(1):74. PubMed ID: 32552732
[TBL] [Abstract][Full Text] [Related]
33. Role of pattern recognition receptors in sensing
Zihad SMNK; Sifat N; Islam MA; Monjur-Al-Hossain ASM; Sikdar KMYK; Sarker MMR; Shilpi JA; Uddin SJ
Heliyon; 2023 Oct; 9(10):e20636. PubMed ID: 37842564
[No Abstract] [Full Text] [Related]
34. Mycobacterium tuberculosis and its clever approaches to escape the deadly macrophage.
Krishnan V; Nath S; Nair P; Das B
World J Microbiol Biotechnol; 2023 Sep; 39(11):300. PubMed ID: 37667129
[TBL] [Abstract][Full Text] [Related]
35. Initial immune response after exposure to
Aiello A; Najafi-Fard S; Goletti D
Front Immunol; 2023; 14():1244556. PubMed ID: 37662901
[TBL] [Abstract][Full Text] [Related]
36. Human Airway Epithelium Responses to Invasive Fungal Infections: A Critical Partner in Innate Immunity.
Crossen AJ; Ward RA; Reedy JL; Surve MV; Klein BS; Rajagopal J; Vyas JM
J Fungi (Basel); 2022 Dec; 9(1):. PubMed ID: 36675861
[TBL] [Abstract][Full Text] [Related]
37. Pathogenicity and virulence of
Rahlwes KC; Dias BRS; Campos PC; Alvarez-Arguedas S; Shiloh MU
Virulence; 2023 Dec; 14(1):2150449. PubMed ID: 36419223
[No Abstract] [Full Text] [Related]
38. Immune evasion and provocation by Mycobacterium tuberculosis.
Chandra P; Grigsby SJ; Philips JA
Nat Rev Microbiol; 2022 Dec; 20(12):750-766. PubMed ID: 35879556
[TBL] [Abstract][Full Text] [Related]
39. Advancing Lung Immunology Research: An Official American Thoracic Society Workshop Report.
Rahimi RA; Cho JL; Jakubzick CV; Khader SA; Lambrecht BN; Lloyd CM; Molofsky AB; Talbot S; Bonham CA; Drake WP; Sperling AI; Singer BD
Am J Respir Cell Mol Biol; 2022 Jul; 67(1):e1-18. PubMed ID: 35776495
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
